baber/WOPTO huggingface dataset:
Patent NZ-502908-A (NZ)
Title: Inline fluid mixing apparatus where the mixing nozzle for introducing a first fluid into an other is responsive to pressure of the other fluid
Inventor: DALLEY PAUL NICHOLAS
IPC: B01F5/06
Filed: 1998-09-02
Abstract: Apparatus (10) such as an inline mixer for introducing a first fluid into a second fluid. The apparatus (10) comprises a body (25) defining a first space (45) for receiving the first fluid under pressure. The body (25) includes means (41, 42) providing an outlet opening (64) through which the first fluid can discharge into the second fluid, such means being responsive to the first fluid whereby the outlet opening (64) is established when the fluid pressure of the first fluid is at or exceeds a predetermined pressure and the outlet opening (64) is closed when the fluid pressure of the first fluid is below that predetermined pressure. Typically the means (42) providing the outlet opening (64) comprises first and second sections (41, 42) moveable relative to each other between a first condition in which the first and second sections are in spaced apart relationship to define the outlet opening (64) and a second condition in which the first and second sections are in sealing contact so as to close said outlet opening.
Patent NZ-505802-A (NZ)
Title: Flashlight having lens held in a fixed position relative to light holder when reflector is moved
Inventor: HALASZ STEPHEN SANDOR
IPC: F21V9/16
Filed: 1999-01-26
Abstract: A flashlight (10) is described that includes a chamber (20), end cap (30), head assembly (40) and lamp holder assembly (50).  The end cap includes a bowed tripod portion to facilitate standing the flashlight on a flat surface.  The head assembly includes a reflector and a lens. In one embodiment, the head assembly includes an elliptical reflector. In accordance with another embodiment, the flashlight having an elliptical reflector is matched with a negative or planar lens.  In accordance with another embodiment, the head assembly includes a hyperbolic reflector.  In accordance with another embodiment, the flashlight having a hyperbolic reflector is matched with a positive or planar lens.  In accordance with another aspect, the flashlight includes electrode connections, which prevent the conduction of electrical energy from batteries that are improperly aligned within the flashlight.  In another embodiment, the lamp holder assembly includes a lamp socket having a lamp guide, which provides a guide for installing lamp bulbs into the lamp socket and also provides a secure position for the lamp bulb.  In another embodiment, the lamp holder assembly further includes a fluorescent coating or additive which illuminates light in otherwise dark conditions, thereby facilitating lamp replacement in the less than desirable light conditions.  In another embodiment, the flashlight comprises a head assembly attached to the chamber, which is rotatable relative to the chamber to cause electrical coupling of a lamp and one or more batteries retained by a chamber.  In another embodiment of the flashlight, the spare lamp is held secure by the lamp holder assembly until the user of the flashlight rotates the lamp holder assembly to align a spare lamp opening with the spare lamp.
Patent NZ-506341-A (NZ)
Title: Genetic manipulation of spermatogonia
Inventor: DITULLIO PAUL A
IPC: C12N15/87
Filed: 1999-02-09
Abstract: A method of delivering DNA to a spermatogonium comprises infusing in situ DNA into a testicle of a prepubertal non-human animal and then administrating a condition or a substance to the testicle to increase uptake of the DNA by the spermatogonium. The condition may be the passage of an electrical current through the testicle. Also described is a method of making a non-human transgenic animal comprising the steps of infusing in situ DNA into a testicle of a prepubertal non-human animal. Then harvesting the sperm cells from the animal. An ovum is contacted with the sperm cells under conditions suitable for fertilization to produce the non-human transgenic animal.
Patent NZ-510275-A (NZ)
Title: Controlled-release pharmaceutical formulations containing a CGMP PDE-5 inhibitor
Inventor: MACRAE ROSS JAMES
IPC: A61K9/22
Filed: 1999-10-04
Abstract: Controlled-release formulations for oral administration containing a cGMP PDE-5 inhibitor. The formulations are useful, inter alia, in the treatment or prevention of sexual dysfunction.
Patent NZ-510975-A (NZ)
Title: A cabinet characterised by a movable member connected to a drawstring which releases the retaining arm so that the cabinet lid may be removed
Inventor: SIMS DAVID JOHN
IPC: A47B96/00
Filed: 2001-04-05
Abstract: A mounting method for a handrail in a frame scaffolding, in a frame scaffolding in which a plurality of frames comprising fittings and a lateral member are stood apart, a scaffolding plate is erected between the lateral members, a handrail is erected between the fittings adjacent to each other laterally to constitute a scaffolding frame, and a plurality of said scaffolding frames are assembled vertically, said handrail comprising a pair of longitudinal struts opposed laterally, and a lateral handrail frame erected between the struts, said strut including a first mounting member mounted on the lateral member or the fittings, a second mounting member mounted on the fittings, and a third mounting member for receiving an end of the handrail frame, the method comprising the steps of: mounting said one strut on the upper end of one fittings through the first and second mounting members on the scaffolding plate of the lower stage; mounting one end of the handrail frame on said one strut through the third mounting member on the scaffolding plate of the lower stage; mounting the other strut on the other end of said handrail frame through the third mounting member on the scaffolding plate of the lower stage; raising said other strut while rotating the other end upward about one end of said handrail frame on the scaffolding plate of the lower stage; and mounting the other fittings on the upper end of the other strut through the first and second mounting members on the scaffolding plate of the lower stage.
Patent NZ-510991-A (NZ)
Title: Use of formulations for hydrophobic pharmaceutical agents in treatment or prevention of cell proliferative disorders
Inventor: SHENOY NARMADA
IPC: A61K47/44
Filed: 1998-03-04
Abstract: A formulation containing: a) 3-[(2,4-dimethylpyrrol-5-yl)methylene]-2-indolinone at concentrations of 6 mg/ml; b) one or more polyoxyhydrocarbyl compounds and c) one or more pharmaceutically acceptable surfactants wherein one of the surfactants is PEG-400 at a concentration of 0.01-10g/ml and at least one of the polyoxyhydrocarbyl compounds is ethoxylated castor oil at a concentration of 0.01-10 g/ml. A formulation containing: a) 3-[(2,4-dimethylpyrrol-5-yl)methylene]-2-indolinone at concentrations of 4.5 mg/ml; b) 0.45g/ml pf PEG-400; c) 0.315 g/ml of CREMAPHOR EL; d) 20 mg benzyl alcohol; and e) 0.095g/ml of ethanol. These formulations can be used to treat abnormal conditions such as cell proliferative disorders.
Patent NZ-513514-A (NZ)
Title: Antimicrobial peptide
Inventor: OLSEN HENRIK S
IPC: C12N15/12
Filed: 1998-03-14
Abstract: An  isolated  antibody that binds  specifically  to  a defensin antimicrobial peptide of a defined sequence  and  a method   of  detecting  antimicrobial  proteins  using   the antibody.
Patent NZ-515902-A (NZ)
Title: Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, and type 2 diabetes
Inventor: LUSKEY KENNETH L
IPC: A61K31/425
Filed: 2000-06-02
Abstract: The present invention provides the use of (-) (3- trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives and compositions in the treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia.
Patent NZ-517545-A (NZ)
Title: Compositions comprising a lipase inhibitor, at least one surfactant and at least one dispersant
Inventor: DE SMIDT PASSCHIER CHRISTIAAN
IPC: A61K31/365
Filed: 2000-09-11
Abstract: Described are pharmaceutical compositions comprising at least one lipase inhibitor, preferably an inhibitor of gastrointestinal and pancreatic lipases, e.g. orlistat, at least one non-ionic surfactant, zwitterionic surfactant or mixtures thereof, and at least one dispersant. Such compositions are shown to have increased efficacy and/or potency of the lipase inhibitor itself.
Patent NZ-518951-A (NZ)
Title: Dip coating compositions containing starch or dextrin with a surface gloss value of at least 150 and contains less than 1% gelatine
Inventor: GULIAN CYNTHIA
IPC: A61K9/36
Filed: 2002-05-14
Abstract: A  film  forming composition which possess  a  surface gloss  of  at  least 150 when applied via dip coating  to  a substrate comprises: a)  a film former selected from a waxy maize starch, tapioca dextrin,  a  derivative of a waxy maize starch, a derivative of tapioca dextrin or mixtures thereof, and b) A thickener selected from sucrose, dextrose, fructose and mixtures thereof, and c) A plasticizer or the composition can comprise: a) a hydroxypropyl starch film former, and b)   a  thickener  selected  from  kappa  carrageenan,  iota carrageenan, maltodextrin, gellan gum, agar, gelling  starch and mixtures thereof, and c) a plasticizer The  composition  can  be  used  as  an  outer  coating  for pharmaceuticals dosage forms. Coated tablets can be made  by dip  coating  the  tablets in an aqueous dispersion  of  the composition
Patent NZ-520987-A (NZ)
Title: Gripper plate construction for cartridge dispensing guns, with plates having circular holes with angled portions to limit penetration into and reduce scoring marks on rod
Inventor: GREENHILL SILVIU
IPC: B05C17/005
Filed: 2001-02-15
Abstract: A cartridge dispensing gun comprises a pusher mechanism for incrementally displacing a dispensing piston of the cartridge, said pusher mechanism comprising a pusher rod (4) incrementally advanced by actuation of a trigger to tilt and displace a gripper associated with the rod. The gripper is formed by two or more gripper plates (16) mounted in parallel, and each having a passage through which the rod passes. The passage in the gripper plate is bounded at one side of the gripper plate by an arc of part-circular shape to define a part-circular edge which grips the rod when the gripper plate is tilted upon actuation of the trigger and also by a surface which is inclined to the axis of the passage and which contacts the surface of the rod when the gripper plate is tilted to thereby restrict the extent to which the edge can penetrate into the rod and cause damaging scoring of the rod. Such gripper plate construction per se is also claimed
Patent NZ-523177-A (NZ)
Title: Insulation panel having a different density at its core to its outer surface
Inventor: THOMPSON PATRICK ANDREW
IPC: E04C2/20
Filed: 2002-12-16
Abstract: A moulded demountable bulkhead insulation panel for temperature insulation compartment when used in the transportation of goods comprises a body having an outer surface, a core and in use the panel has a top, base and sides. The core comprises at least one insulation material not consisting of plies. The core material can have a different density from the centre portion to the outer portion. The outer surfaces can be a skin or skeletal in form or can be a separate member.
Patent NZ-523184-A (NZ)
Title: 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor Xa inhibitors
Inventor: PINTO DONALD J P
IPC: C07D487/04
Filed: 2001-06-22
Abstract: Described are compounds of formula Ia, Ib and Ic, wherein: D1, D2 and D3 are heteroaromatic rings systems, Q is a group of formula II, in which M is a optionally substituted 6 or 7-membered carbocycle, or 6 or 7-membered heterocycle, and P is a 5-membered heterocycle with heteroatoms selected from N, S and O. The compounds are used in the manufacture of medicaments for the treatment of thromboembolic disorders.
Patent NZ-528667-A (NZ)
Title: Methods of using hop acids to control organisms in aqueous systems
Inventor: CRONAN JOHN M
Filed: 2001-03-28
Abstract: Disclosed herein are methods of inhibiting the growth of organisms in aqueous systems such as papermaking systems, cooling systems and process waters of various types, which process water does not contact a final product, wherein the microorganism comprises at least one Gram-negative bacteria which causes biofouling in said system, wherein the process comprises adding to the aqueous system an effective amount of one or more hop acids at a pH of at least 5.5 to inhibit the growth of the said organism in the said system. Compositions comprising hop acids and papermaking suspensions or slurries, and/or additives, such as paper making additives, are also provided.
Patent NZ-528966-A (NZ)
Title: Peptide nucleic acid conjugates and uses thereof
Inventor: ECCLES ROGER MICHAEL
IPC: A61P31/00
Filed: 2003-10-17
Abstract: Disclosed is a conjugate of formula I, wherein: L is a linker group, S-Z is a thiol-containing attachment group, X- is an optional anion and PNA is a peptide nucleic acid. The conjugate can be used in the preparation of a medicament for the treatment of a disease or disorder that can be at least in part alleviated by antisense therapy, for modifying gene expression or altering RNA function or processing.
Patent NZ-530520-A (NZ)
Title: A method for assessing levels of expression of GST-pi mRNA from fixed and paraffin-embedded (FPE) tissue samples and tumour cells
Inventor: DANENBERG KATHLEEN D
IPC: A61K33/243
Filed: 2002-05-15
Abstract: Described are prognostic methods which are useful in medicine, particularly cancer chemotherapy. The object is to provide a method for assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues and prognosticate the probable resistance or sensitivity of a patient's tumour to treatment with platinum-based therapies by examination of the amount of GST-pi mRNA in a patient's tumour cells and comparing it with a predetermined threshold expression level. More specifically, described are oligonucleotide primer pairs for GST-pi and methods comprising their use for detecting levels of GST-pi mRNA.
Patent NZ-531294-A (NZ)
Title: Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
Inventor: SHAH JAMSHED H
IPC: A61K31/454
Filed: 2002-08-06
Abstract: An angiogenesis-inhibiting compound is described to be used for the manufacture of a composition for the treatment of undesired angiogenesis in a human or animal. The undesired angiogenesis is disclosed to be associated with diseases such as retinal/choroidal neovascularization, corneal neovascularization, retinopathy of prematurity, or neovascular glaucoma. The compound comprises the formula A, B, or C, or combinations thereof, wherein: R1 is independently -H, -OH, -CH3, -CH2OZ, -CH2OCONZ, or -CH2Z, wherein Z is H or -(CH2)n-H, where n is 1-10; R2 is independently selected from -NH-NH2, -NH-OH, -NH-OR3, -N=N-R3, -N(R3)2, -NHCOH, -NHCOCH3, pyrazolidine, or imidazoline; and R3- is independently selected from pyrazolidine, pyrazoline, tetrazole, imidazole, pyrazole, piprazine, or imidazoline.
Patent NZ-531883-A (NZ)
Title: Global management of device data
Inventor: OED ROGER GORDON
Filed: 2004-04-23
Abstract: A method of global management of device data is disclosed, whereby the method is supported by a software system and optional apparatus. The device data is potentially shared within an organisation and between organisations, particularly where the devices and/or the organisations are geographically distributed. The method includes the stages of: (a) "security clearance" which includes the establishment of access rights of all potential users, (b) "meta data" which includes the definition of the types of data to be stored, and provides the foundation on which controlled data entry and error checking of the third stage are based, and (c) "operation" which allows entry of the actual data required for the business processes. The method is multi-lingual such that the method may accommodate the worldwide variations in languages, devices, and localised administrative processes. Additionally, the method is adapted to model a life cycle of device data, where the model of the life cycle of data includes design, installation, maintenance, and decommissioning, as well as providing for secured, automated, and global accessibility to the method.
Patent NZ-534774-A (NZ)
Title: Composition for clear gas barrier laminate membranes for cushioning devices for shoes
Inventor: WATKINS RICHARD L
IPC: C08L29/04
Filed: 2003-03-06
Abstract: Disclosed herein is an article of footwear, comprising an upper and a sole attached to said upper, said sole comprising a fluid-filled bladder comprising a laminate membrane, wherein said laminate membrane comprises at least a first layer comprising a thermoplastic polyurethane and a copolymer of ethylene and vinyl alcohol, wherein said thermoplastic polyurethane includes at least about 50 mole percent, based on the total moles of hydroxyl-functional reactants used to produce the polyurethane, of a polyester diol having a weight average molecular weight of at least about 500 and having a linear alkylen group having from two to about six carbon atoms between substantially all of the ester groups and a second layer comprising a copolymer of ethylene and vinyl alcohol ; wherein at least a part of said membrane forms at least a part of an exterior portion of said sole, and wherein the first layer has a haze of not more than about 12%; and a second layer comprising a copolymer of ethylene and vinyl alcohol; wherein at least a part of said membrane forms at least a part of an exterior portion of said sole. Also disclosed is a scrap material having both a thermoplastic polyurethane and a copolymer of ethylene and vinyl alcohol which is recycled by blending the scrap material into a thermoplastic polyurethane composition and preparing a barrier membrane from the blended material. The virgin thermoplastic polyurethane and the thermoplastic polyurethane of the scrap material are polymerized using at least about 60 percent by weight, based on the weight of the polyurethane produced, of a polyester diol having a weight average molecular weight of at least about 500 and having from four to five carbon atoms between substantially all of the ester [-O-C(=O)-] groups. The blend material containing the virgin thermoplastic urethane and the scrap material is formed into a layer of a barrier membrane. The resulting membrane has a haze of no more than about 12%.
Patent NZ-537469-A (NZ)
Title: N,N-disubstituted diazocycloalkanes useful for the treatment of CNS disorders due to serotonergic dysfunction
Inventor: LEONARDI AMEDEO
IPC: A61P15/10
Filed: 2003-06-16
Abstract: A compound of formula (I) wherein, R1 represents a halogen atom, R2 represents a (C3-C8)-cycloalkyl group, R3 represents a (C1-C4)-alkoxy or (C1-C4)-haloalkoxy group, m is 1 or 2, and n is 1 or 2, or an enantiomer, optical isomer, diastereomer, N-oxide, crystalline form, hydrate, solvate or pharmaceutically acceptable salt thereof.
Patent NZ-538099-A (NZ)
Title: Determination of the digestibility of proteins by amino acid profile analysis of total and soluble portions of an infant formula sample digested in vitro with USP digestive enzymes
Inventor: JOHNS PAUL W
IPC: G01N33/02
Filed: 2003-07-30
Abstract: A method for in vitro determination of the digestibility of proteins in a nutritional product such as infant formula. The method utilizes gastric and intestinal enzymes that are standardized for in vitro digestion process that mimics the in vivo digestive process. Further, specificity in digestion is determined by an amino acid profile.
Patent NZ-541038-A (NZ)
Title: Finned tube for heat exchangers, heat exchanger, apparatus for fabricating heat exchanger finned tube and process for fabricating heat exchanger finned tube
Inventor: WATANABE ISAO
IPC: F28D1/047
Filed: 2003-12-09
Abstract: A plurality of fin groups 12 each comprising parallel plate fins 14 are arranged on two straight tube portions 11a of a fin fixing hairpin tube 11 longitudinally of the tube portions at a spacing, by forming two tube inserting holes (not shown) as spaced apart in each of the plate fins 14 and inserting the two straight tube portions 11a through the respective holes of the plate fins 14. The hairpin tube 11 is enlarged with use of a fluid to fixedly fit the plate fins 14 of the fin groups 12 around the straight tube portions 11a of the tube 11. The straight tube portions 11a of the tube 11 each have a finless part 13 provided between each pair of adjacent fin groups 12. The finless part 13 of each straight tube portion 11a bears clamp marks 19 on the outer peripheral surface thereof. A heat exchanger comprising a heat exchanger finned tube 10 thus constructed is adapted to diminish leakage of the refrigerant and achieves a desired refrigeration efficiency.
Patent NZ-541780-A (NZ)
Title: Use of an antibacterial agent and a second agent that is an anti-inflammatory agent, an analgesic and/or an antipyretic with a amphiphatic oil as a vehicle
Inventor: BRITTEN NANCY J
IPC: A61K47/44
Filed: 2004-03-10
Abstract: Disclosed is the use of an antibacterial and a second agent in the manufacture of a medicament for the treatment of an infective condition in a fluid-containing organ having a natural exterior orifice, such as the udder of a milk producing animal or an ear. The antibacterial agent and, optionally, the second agent, are administered as a pharmaceutical composition further comprising a vehicle being an amphipathic oil that is water dispersible and ethanol insoluble, microcrystalline wax and a pharmaceutically acceptable non-aqueous carrier. Further disclosed is a composition comprising the antibacterial agent and the second agent. The composition is readily dispersible in the fluid of the fluid-containing organ.
Patent NZ-549631-A (NZ)
Title: A mechanical shaft seal using a super elastic memory metal to help prevent wear to the seal
Inventor: LAITINEN KARI
IPC: F16J/
Filed: 2005-02-08
Abstract: An arrangement in a mechanical shaft seal is disclosed. Parts subjected to stress in the seal are made from material that exhibits super elasticity to increase their work life. Included in the seal is at least one first sliding surface part (2) rotating with a shaft (14) in relation to a frame (13) of a device, at least one second sliding surface part (4) fastened to the frame (13) and/or to a separate frame part (3) that is non-rotatable in relation to the frame (13). The first sliding surface part (2) and second sliding surface part (4) are provided with sliding surfaces (15) pressed against one another. A first additional part (7) such as a draw pin is arranged to connect the first sliding surface part (2) to at least one of the shaft (14) and a first insertion ring (1) fastened to the shaft (14) and is configured to rotate with it in order to transfer the rotating motion from the shaft (14) to the first sliding surface part. A second additional part (8) is arranged to connect the second sliding surface part (4) to the frame (13) or at least to one second insertion part (6) connected to the frame (13) in order to prevent the rotation of the second sliding surface part (4) in relation to the frame (13). The first additional part (7) is arranged to transfer the rotation torque of at least one of the shaft (14) and the second additional part (8) receiving torque. The first (7) and second (8) additional parts are both made from a super elastic memory metal element arranged to bend within the limits of the reversible deformation of the material.
Patent NZ-554440-A (NZ)
Title: Aryloxy-substituted benzimidazole derivatives
Inventor: HASHIMOTO NORIAKI
IPC: A61K31/4439
Filed: 2005-11-01
Abstract: Disclosed is a glucokinase activator compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein Q represents a carbon atom, a nitrogen atom or a sulfur atom optionally substituted with one or two oxo groups, X represents a carbon atom, ring A represents a 5-or 6-membered nitrogen-containing heteroaromatic group and wherein the rest of the substituents are disclosed within the specification.